Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis

被引:2
|
作者
Chay, TR
机构
[1] Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
关键词
bifurcation analysis; critical ring size; proarrhythmia by antriarrhythmic drugs; conduction velocity;
D O I
10.1016/S0022-0736(95)80055-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study employs a bifurcation analysis approach to elucidate the effect of the key ion channels on cardiac arrhythmias and thereby explain the efficacy of antiarrhythmic drugs in controlling arrhythmias. The model used for the analysis contains the key ion channels involved in the ventricular action potential-fast sodium, slow calcium, and background potassium channels. The cardiac tissue is modeled by a ring structure. The bifurcation diagram reveals that at a certain ring size, the amplitude of the action potential suddenly shrinks and the conduction velocity (CV) becomes unstable. Instability in CV leads to termination of reentrant arrhythmias. This ring size (ie, the critical ring size [CRS]) depends on the type of channel blocker. Blocking of the sodium channel leads to a decrease in the CRS, which in turn enhances stable reentry (proarrhythmia). Although calcium channel blockers do not alter the CV, they can exert the proarrhythmic effect by drastically shortening the CRS. The potassium channel blockers, on the other hand, are effective in controlling reentry in ventricular tissues by lengthening the CRS. Near blocking of the potassium channel, however, brings about another type of arrhythmia-the formation of ectopic foci. In the neighborhood of the CRS, the cycle length oscillates with an interesting pattern that depends on ring size and drug type. Although a critical reentrant loop length for stable reentrant excitation has been investigated for a long time, this study is the first demonstration of how the key ion channels in the plasma membrane affect the loop length. Furthermore, the analysis approach provides a theoretical basis for the increased mortality associated with class I drug use in the Cardiac Arrhythmia Suppression Trial Team.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 50 条
  • [41] CONGESTIVE HEART-FAILURE AFTER ACUTE MYOCARDIAL-INFARCTION IN PATIENTS RECEIVING ANTIARRHYTHMIC AGENTS FOR VENTRICULAR PREMATURE COMPLEXES (CARDIAC-ARRHYTHMIA PILOT-STUDY)
    GREENE, HL
    RICHARDSON, DW
    HALLSTROM, AP
    MCBRIDE, R
    CAPONE, RJ
    BARKER, AH
    RODEN, DM
    ECHT, DS
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (07): : 393 - 398
  • [42] Comparative analysis between convolutional neural network learned and engineered features: A case study on cardiac arrhythmia detection
    Mahajan, Ruhi
    Kamaleswaran, Rishikesan
    Akbilgic, Oguz
    CARDIOVASCULAR DIGITAL HEALTH JOURNAL, 2020, 1 (01): : 37 - 44
  • [43] STUDY OF SOME CENTRAL-ACTING DRUGS ON THE CORTICAL EEG BY TOPOGRAPHICAL ANALYSIS
    ISHIKAWA, T
    YAMANOUCHI, K
    SAEKI, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1985, 39 : P360 - P360
  • [44] The Effect of Time to Treatment With Antiarrhythmic Drugs on Outcome in Shock Refractory Out-of-Hospital Cardiac Arrest: A Secondary Analysis of the ALPS Randomized Controlled Trial
    Rahimi, Mahbod
    Dorian, Paul
    Cheskes, Sheldon
    Lebovic, Gerald
    Lin, Steve
    CIRCULATION, 2020, 142 (24) : E496 - E496
  • [45] Analysis of the 2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest
    Sharma, Archit
    Arora, Lovkesh
    Subramani, Sudhakar
    Simmons, Jonathan
    Mohananey, Divyanshu
    Ramakrishna, Harish
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2020, 34 (02) : 537 - 544
  • [46] VENTRICULAR FIBRILLATION THRESHOLD (VFRT) IN EXPERIMENTAL CORONARY OCCLUSION - A COMPARATIVE STUDY ON EFFECT OF G-I-K SOLUTION AND SOME NEW ANTIARRHYTHMIC DRUGS
    SHINOHAR.Y
    HANAOKA, W
    MIYASHIT.H
    WATANABE, S
    YOSHITOS.Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1968, 32 (12S): : 1855 - &
  • [47] WHY DO SOME PATIENTS FAIL TO RESPOND TO VNS? - A RETROSPECTIVE ANALYSIS OF CARDIAC BASED SEIZURE DETECTION (CBSD) THERAPY
    Wysota, B.
    Samarasekera, S.
    Hamilton, P.
    Soryal, I.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (03): : E18 - E18
  • [48] The Effect of Time to Treatment With Antiarrhythmic Drugs on Return of Spontaneous Circulation in Shock Refractory Out-of-Hospital Cardiac Arrest: A Secondary Analysis of the ALPS Randomized Controlled Trial
    Rahimi, Mahbod
    Dorian, Paul
    Cheskes, Sheldon
    Lebovic, Gerald
    Lin, Steve
    CIRCULATION, 2021, 144
  • [49] Antiarrhythmic Drugs for Shock Refractory Secondary Ventricular Fibrillation Following Initial Nonshockable Out-of-Hospital Cardiac Arrest: The Resuscitation Outcomes Consortium Amiodarone, Lidocaine or Placebo Study
    Kudenchuk, Peter J.
    Daya, Mohamud
    Leroux, Brian
    Rea, Tom
    Nichol, Graham
    Morrison, Laurie J.
    Vaillancourt, Christian
    Wittwer, Lynn
    Callaway, Clifton W.
    Christenson, James
    Egan, Debra
    Ornate, Joe P.
    Weisfeldt, Myron L.
    Stiell, Ian G.
    Idris, Ahamed G.
    Aufderheide, Tom P.
    Dunford, James V.
    Colella, M. R.
    Vilke, Gary M.
    Brienza, Ashley M.
    Desvigne-Nickens, Patrice
    Gray, Pamela
    Gray, Randal
    Seals, Norman
    Strait, Ron
    Dorian, Paul
    CIRCULATION, 2016, 134 (25) : E718 - E718
  • [50] Value of EP testing in predicting the clinical outcome of cardiac arrest survivors receiving randomized assignment to ICD or antiarrhythmic drug therapy: A sub-analysis of the Cardiac Arrest Study Hamburg (CASH)
    Cappato, R
    Boczor, S
    Kuck, KH
    CIRCULATION, 2002, 106 (19) : 667 - 667